In connection with the forthcoming Combined General Meeting that will be held on 24 May 2016, at 3:00 pm (Paris Time), in the auditorium of Capital 8, located at 32 rue de Monceau, 75008, Paris, France, Albioma announces that the preparatory documents have been made available to its shareholders. These documents may be consulted on the Company's website, www.albioma.com .
Furthermore, any shareholder may:
Albioma's shareholders will be able to vote via Internet at the General Meeting of Shareholders, using the Votacess platform.
Detailed information on the Internet voting procedure is available on Albioma's website, www.albioma.com ( "General Meetings of shareholders" tab).
Next on the agenda: Ordinary and Extraordinary General Meeting of shareholders at 3 pm on 24 May 2016.
About Albioma
Albioma is an independent energy producer and world leader in the conversion of biomass into a highly-effective source of energy, in collaboration with its agri-business partners. For more than 20 years, Albioma has operated power plants recovering bagasse, a fibrous by-product of sugar cane, replaced by coal outside the sugar cane harvest. Its unique expertise has enabled Albioma to establish itself as an indispensable partner in the sugar and ethanol industry in the French overseas territories and Mauritius. Albioma is now developing power plants using only biomass, which recover, in addition to bagasse, green waste and wood industry residue. The Group also operates a highly-efficient photovoltaic installation and agricultural anaerobic digestion units. In 2014, the Group, which already had a presence in mainland France, the French overseas territories and Mauritius, began operating in Brazil, the world's leading sugar cane producer.
For further information, please visit www.albioma.com
Investor contacts
Julien GauthierMedia contacts - LPM Strategic Communications
Luc Perinet-MarquetAlbioma shares are listed on Euronext Paris (sub B) and eligible for the deferred settlement service (SRD) and PEA-PME plans.
ISIN FR0000060402 - Ticker: ABIO